文献速递浆细胞疾病

血清游离轻链二聚化模式分析辅助诊断AL淀粉样变性

The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis.
PubMed 文献 · Br J Haematol · 2018-05-16

研究以盲法分析AL淀粉样变性和良性浆细胞病患者的血清样本,用定量Western blotting估算二聚化指数和克隆性指数,并与实际诊断比较。37例活动性AL淀粉样变性中34例(91.9%)符合二聚化诊断标准,45例良性浆细胞病中10例(21.2%)假阳性或结果不确定,灵敏度92.5%,阴性预测值91.9%。

要点

  • 活动性AL淀粉样变性患者中91.9%(34/37)符合二聚化诊断标准。
  • 良性浆细胞病患者中21.2%(10/45)假阳性或结果不确定。
  • 灵敏度92.5%,阴性预测值91.9%,多因素分析示FLC-MDPA为最佳独立预测指标(比值比84)。

核心结论

  • 游离轻链单体-二聚体模式分析(FLC-MDPA)为浆细胞病患者诊断评估提供高效工具,有助于区分AL淀粉样变性与良性浆细胞病。

研究设计与样本

  • 对AL淀粉样变性和良性浆细胞病患者的血清样本进行盲法分析,用定量Western blotting估算二聚化指数和克隆性指数以判断样本来源,并与实际诊断比较。

主要发现

  • 37例活动性AL淀粉样变性样本中34例(91.9%)符合AL淀粉样变性二聚化诊断标准。
  • 45例良性浆细胞病样本中10例(21.2%)检测为假阳性或结果不确定。
  • 分析灵敏度为92.5%,阴性预测值为91.9%。
  • 20例完全缓解或非常好的部分缓解患者中仅1例检测阳性。
  • 多因素分析显示FLC-MDPA是预测AL淀粉样变性的最佳独立指标(比值比84)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The discrimination between benign and malignant forms of plasma cell dyscrasia (PCD) is often difficult. Free light chain monomer-dimer pattern analysis (FLC-MDPA) may assist in solving this dilemma and distinguish between AL amyloidosis and benign PCD. Serum samples of patients with AL amyloidosis and benign PCD were analysed in a blinded manner. Quantitative Western blotting was performed to estimate dimerization and clonality indices, and thereby determine the source of the tested samples, as derived either from benign or malignant PCD. The findings obtained by the FLC-MDPA were compared with the actual diagnosis. Of 37 samples from patients with active AL amyloidosis, 34 (91·9%) fulfilled dimerization criteria for diagnosis of AL amyloidosis. Of the 45 samples from patients with benign PCD, 10 (21·2%) tested falsely positive or gave an inconclusive result. Thus, the sensitivity of the analysis was 92·5% with a remarkable negative predictive value of 91·9%. In addition, of 20 patients who were in complete or very good partial remission, only one tested positive. By multivariate analysis, FLC-MDPA was the best independent marker predicting AL amyloidosis (odds ratio of 84). The FLC-MDPA offers a highly effective tool in the diagnostic assessment of patients with PCD.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Gatt ME, Kaplan B, Yogev D, et al. The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis. Br J Haematol. 2018. PMID: 29767409. doi:10.1111/bjh.15387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。